T.Man Pharmaceutical PCL (BKK:TMAN)
Thailand
· Delayed Price · Currency is THB 10.90
-0.40 (-3.54%)
At close: Jun 18, 2025, 4:30 PM ICT
T.Man Pharmaceutical PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 433.1 | 450.7 | 431.09 | 472.52 | 56.39 | 59.89 |
Depreciation & Amortization | 109.71 | 104.83 | 97.87 | 75.09 | 70.36 | 70.69 |
Loss (Gain) From Sale of Assets | -0.35 | -0.35 | -0.58 | 3.52 | 0.17 | -0.71 |
Asset Writedown & Restructuring Costs | 0.07 | 0.07 | 0.01 | - | - | - |
Provision & Write-off of Bad Debts | -1.58 | -3.29 | -44.63 | 40.57 | 11.64 | 5.88 |
Other Operating Activities | 19.64 | 21.27 | -66.84 | 101.77 | 16.04 | 17.06 |
Change in Accounts Receivable | -65.7 | 8.35 | -42.97 | -289.24 | -76.82 | 92.52 |
Change in Inventory | 10.84 | -59.79 | -125.25 | -62.83 | 101.77 | 7.75 |
Change in Accounts Payable | 35.6 | 35.6 | 3.49 | 65.99 | 101.17 | -27.35 |
Change in Unearned Revenue | -19.95 | -28.28 | 26.49 | - | - | - |
Change in Other Net Operating Assets | -5.75 | -9.45 | 3.41 | 116.13 | -5 | -31.66 |
Operating Cash Flow | 515.63 | 519.66 | 282.09 | 523.53 | 275.74 | 194.06 |
Operating Cash Flow Growth | 34.12% | 84.22% | -46.12% | 89.86% | 42.09% | - |
Capital Expenditures | -175.12 | -173.95 | -219.95 | -234.52 | -79.25 | -65.24 |
Sale of Property, Plant & Equipment | 1.09 | 1.09 | 2.33 | - | 1.21 | 1.45 |
Investment in Securities | -550 | -550 | - | - | 5 | - |
Other Investing Activities | 2.66 | 1.83 | 1.24 | 20.08 | 0.05 | 0.43 |
Investing Cash Flow | -721.37 | -721.03 | -216.38 | -177.36 | -72.99 | -63.35 |
Short-Term Debt Issued | - | 929.11 | 28.81 | - | 19.61 | - |
Long-Term Debt Issued | - | - | - | 50 | - | - |
Total Debt Issued | 929.11 | 929.11 | 28.81 | 50 | 19.61 | - |
Short-Term Debt Repaid | - | -352.54 | -60.38 | -79.57 | -210.2 | -60.8 |
Long-Term Debt Repaid | - | -40.52 | -32.82 | -22.8 | -50.84 | -11.48 |
Total Debt Repaid | -366.93 | -393.06 | -93.2 | -102.37 | -261.04 | -72.29 |
Net Debt Issued (Repaid) | 562.18 | 536.05 | -64.4 | -52.37 | -241.43 | -72.29 |
Issuance of Common Stock | 1,164 | 1,164 | 59.13 | - | - | - |
Common Dividends Paid | -1,336 | -1,336 | -11.83 | - | - | - |
Other Financing Activities | -51.34 | -62.99 | -7.75 | -8.82 | -6.03 | -7.56 |
Financing Cash Flow | 339.5 | 301.72 | -24.85 | -61.19 | -247.46 | -79.85 |
Net Cash Flow | 133.76 | 100.35 | 40.86 | 284.98 | -44.71 | 50.86 |
Free Cash Flow | 340.51 | 345.71 | 62.15 | 289.02 | 196.49 | 128.83 |
Free Cash Flow Growth | 74.87% | 456.28% | -78.50% | 47.09% | 52.52% | - |
Free Cash Flow Margin | 15.23% | 15.53% | 3.14% | 14.27% | 15.55% | 14.30% |
Free Cash Flow Per Share | 0.94 | 1.01 | 0.23 | 1.16 | 2.72 | 1.93 |
Cash Interest Paid | 22.94 | 34.58 | 7.75 | 8.62 | 6.03 | 8.56 |
Cash Income Tax Paid | 77.87 | 77.68 | 164.55 | 50.32 | 14.53 | 7.35 |
Levered Free Cash Flow | - | -247.75 | -46.49 | 159.27 | 193.69 | - |
Unlevered Free Cash Flow | - | -236.11 | -37.2 | 169.88 | 198.18 | - |
Change in Net Working Capital | - | 510.72 | 243.28 | 50.82 | -156.44 | - |
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.